The markets traded flat during the midday with the Dow edging up 6 points to 11,566 as Fitch Ratings downgraded Portugal's credit rating. Nasdaq slipped 5 points to 2665.
On the upside
Repros Therapeutics (Nasdaq: RPRX) submitted data to the Food and Drug Administration for its Androxal testosterone treatment.
Goldman Sachs initiated coverage of ReneSola (NYSE: SOL) with a Buy rating and an $11 price target.
E-Commerce China Dangdang (NYSE: DANG) will expand beyond media offerings to compete against Alibaba Group's Taobao.
On the downside
Arrowhead Research (NYSE: ARWR) narrowed fourth quarter losses but revenue fell.
Capstone Investments analyst Carter Driscoll initiated coverage of Tesla Motors (Nasdaq: TSLA) with a Sell rating and a price target of $22.
Micron Technology (Nasdaq: MU) disappointed with lower first quarter earnings that fell short of analyst expectations.
In the broad market, advancing issues were on par with decliners on the NYSE while decliners edged out advancers by a margin of 9 to 7 on Nasdaq. The Russell 2000 which tracks small cap stocks held steady at 790.
